{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:32:49Z","timestamp":1788474769187,"version":"build-2803163510"},"reference-count":36,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2024,12,23]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Maintaining good cardiopulmonary fitness is crucial for global health in cystic fibrosis (CF), but there is limited knowledge about the longitudinal evolution of fitness measures at young ages, particularly with recent therapeutic advances. We investigated trends in exercise test outcomes in young people with CF and how they are influenced by elexacaftor, tezacaftor and ivacaftor (ETI) and the coronavirus disease 2019 (COVID-19) pandemic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>70 young people with CF (12\u201320\u2005years old) were included in this retrospective observational single-centre study. We reviewed 177 symptom-limited surveillance cardiopulmonary exercise tests (CPETs) conducted on a cycle ergometer between 2010 and 2024. Longitudinal trends in peak oxygen uptake (<jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub>), maximal workload and ventilation were analysed using linear mixed models, separately for periods before and after the COVID-19 pandemic onset and ETI introduction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In ETI-naive people with CF, <jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub> was lower, and the increase from 12 to 20\u2005years was smaller than predicted by validated reference data (p&lt;0.001). 40 people with CF started ETI during the observational period with 46 of 103 tests performed under ETI (median therapy duration 1.6\u2005years, range 0.4\u20133.9). After ETI introduction, <jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub> improved significantly, whereas ventilation and maximal workload were not relevantly affected. ETI approval coincided with the COVID-19 pandemic, during which a steeper decline of <jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub> in ETI-naive people with CF was observed. However, this potential confounder did not significantly impact the overall longitudinal improvement in <jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub> trajectory following ETI introduction (p&lt;0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The longitudinal trend in <jats:italic>V<\/jats:italic>\u2032<jats:sub>O<jats:sub>2<\/jats:sub>\n                     <\/jats:sub>\n                     <jats:sub>peak<\/jats:sub> progression from adolescence to young adulthood is impaired in people with CF, but the initiation of ETI can have a positive impact on this trajectory.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1183\/23120541.00971-2024","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T15:25:36Z","timestamp":1737645936000},"page":"00971-2024","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term exercise capacity in paediatric cystic fibrosis: a modern era perspective"],"prefix":"10.1183","volume":"11","author":[{"given":"Ren\u00e9","family":"Gaupmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"St\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Schmidthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Pauger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Mersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Sz\u00e9pfalusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Dehlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025070707350461000_11.4.00971-2024.1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00508-017-1179-x","article-title":"Cystic fibrosis in Austria","volume":"129","author":"Frischer","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"2025070707350461000_11.4.00971-2024.2","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.3390\/ijerph18105375","article-title":"Comparison of physical activity and sedentary behaviour between schoolchildren with cystic fibrosis and healthy controls: a gender analysis","volume":"18","author":"Valencia-Peris","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025070707350461000_11.4.00971-2024.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2012.01.001"},{"key":"2025070707350461000_11.4.00971-2024.4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.201806-1110OC","article-title":"Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis","volume":"199","author":"Hebestreit","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2025070707350461000_11.4.00971-2024.5","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008102"},{"key":"2025070707350461000_11.4.00971-2024.6","doi-asserted-by":"crossref","first-page":"881470","DOI":"10.3389\/fped.2022.881470","article-title":"Translational research in cystic fibrosis: from bench to beside","volume":"10","author":"Garcia","year":"2022","journal-title":"Front Pediatr"},{"key":"2025070707350461000_11.4.00971-2024.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2025070707350461000_11.4.00971-2024.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.03.002"},{"key":"2025070707350461000_11.4.00971-2024.9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcf.2024.04.010","article-title":"Changes in exercise capacity in people with cystic fibrosis after one year of elexacaftor\/tezacaftor\/ivacaftor treatment - a Danish prospective cohort","volume":"23","author":"Philipsen","year":"2024","journal-title":"J Cyst Fibros"},{"key":"2025070707350461000_11.4.00971-2024.10","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26078"},{"key":"2025070707350461000_11.4.00971-2024.11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ppul.26243","article-title":"Effect of trikafta on bone density, body composition and exercise capacity in CF: a pilot study","volume":"58","author":"Gur","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2025070707350461000_11.4.00971-2024.12","unstructured":"OECD . Policies. Austria, Country Health Profile, 2021."},{"key":"2025070707350461000_11.4.00971-2024.13","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.lanepe.2023.100748","article-title":"Physical fitness among children with diverse weight status during and after the COVID-19 pandemic: a population-wide, cohort study based on the Slovenian physical fitness surveillance system (SLOfit)","volume":"34","author":"Martinko","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2025070707350461000_11.4.00971-2024.14","unstructured":"Bongers BC , Hulzebos HJ , van Brussel M , et al. Pediatric Norms for Cardiopulmonary Exercise Testing, 2nd Edn. 's Hertogenbosch, the Netherlands : Uitgeverij BOXPress; 2014."},{"key":"2025070707350461000_11.4.00971-2024.15","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0101-2018"},{"key":"2025070707350461000_11.4.00971-2024.16","doi-asserted-by":"publisher","DOI":"10.1159\/000439057"},{"key":"2025070707350461000_11.4.00971-2024.17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1123\/pes.2018-0235","article-title":"A systematic approach to interpreting the cardiopulmonary exercise test in pediatrics","volume":"31","author":"Van Brussel","year":"2019","journal-title":"Pediatr Exerc Sci"},{"key":"2025070707350461000_11.4.00971-2024.18","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1152\/jappl.1999.87.6.2230","article-title":"Modeling growth and maturation changes in peak oxygen uptake in 11-13\u2005yr olds","volume":"87","author":"Armstrong","year":"1999","journal-title":"J Appl Physiol (1985)"},{"key":"2025070707350461000_11.4.00971-2024.19","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00056-2018"},{"key":"2025070707350461000_11.4.00971-2024.20","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000001559"},{"key":"2025070707350461000_11.4.00971-2024.21","unstructured":"Wasserman KHJ , Sue DY , Stringer WW , et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. Philadelphia: Lippincott Williams & Wilkins, 2005."},{"key":"2025070707350461000_11.4.00971-2024.22","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2019.1627874"},{"key":"2025070707350461000_11.4.00971-2024.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2025070707350461000_11.4.00971-2024.24","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080312"},{"key":"2025070707350461000_11.4.00971-2024.25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcf.2022.09.006","article-title":"Clinical outcomes of adults and children with cystic fibrosis during the COVID-19 pandemic","volume":"22","author":"Doumit","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2025070707350461000_11.4.00971-2024.26","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00687-2023"},{"key":"2025070707350461000_11.4.00971-2024.27","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00333-2020"},{"key":"2025070707350461000_11.4.00971-2024.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.167.2.211"},{"key":"2025070707350461000_11.4.00971-2024.29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fped.2014.00033","article-title":"Body composition and pulmonary function in cystic fibrosis","volume":"2","author":"Sheikh","year":"2014","journal-title":"Front Pediatr"},{"key":"2025070707350461000_11.4.00971-2024.30","doi-asserted-by":"crossref","first-page":"101466","DOI":"10.1016\/j.diabet.2023.101466","article-title":"Effects of elexacaftor \/ tezacaftor \/ ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes","volume":"49","author":"Grancini","year":"2023","journal-title":"Diabetes Metab"},{"key":"2025070707350461000_11.4.00971-2024.31","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ppul.26388","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on body composition in a small cohort of youth with cystic fibrosis","volume":"58","author":"Granados","year":"2023","journal-title":"Pediatr Pulmonol"},{"key":"2025070707350461000_11.4.00971-2024.32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2021.11.011","article-title":"Exercise intolerance in cystic fibrosis-the role of CFTR modulator therapies","volume":"21","author":"Caterini","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2025070707350461000_11.4.00971-2024.33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/02701367.2024.2320234","article-title":"Longitudinal evaluation of physical fitness in adults with cystic fibrosis in the era of CFTR-modulating-therapies","volume":"95","author":"Welsner","year":"2024","journal-title":"Res Q Exerc Sport"},{"key":"2025070707350461000_11.4.00971-2024.34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcf.2022.05.009","article-title":"Change in exercise capacity measured by cardio-pulmonary exercise testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with lumacaftor\/ivacaftor and tezacaftor\/ivacaftor","volume":"21","author":"Rysgaard","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2025070707350461000_11.4.00971-2024.35","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.3.291"},{"key":"2025070707350461000_11.4.00971-2024.36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2020.12.006","article-title":"VO2max as an exercise tolerance endpoint in people with cystic fibrosis: lessons from a lumacaftor\/ivacaftor trial","volume":"20","author":"Wilson","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00971-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T14:35:19Z","timestamp":1751898919000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00971-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,7,7]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1183\/23120541.00971-2024"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00971-2024","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]}}}